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The articleby Mayranpaa and colleagues provides novel and
detailed results from a study of human aortic tissue examining the
The authors use a combination of basic histology, immunohisto-
chemistry, and real-time polymerase chain reaction (PCR) to fur-
ther define the inter-relationship of the “big four” factors in
JOURNAL OF VASCULAR SURGERY
August 2009396 Rasmussenaneurysm pathogenesis: mural thrombus, inflammatory infiltrates
(mast cells in this study), neovascularization, and degeneration. At
a time when access to tissue from diseased human aorta is limited,
this investigation makes maximum use of specimens obtained at
the time of open aneurysm repair and provides unique comparison
of these samples to non-diseased aortic specimen from organ
donors and medicolegal autopsies. The number and variety of
aortic samples and the detail of analysis combine to make the
results of the study powerful and convincing.
The results of the investigation confirm histologic studies that
demonstrate aneurysm pathogenesis to be an immune-mediated
disease. Importantly, however, this study provides new and com-
pelling data that mast cells in particular play an important and
unique role in this process. Furthermore, this article provides an
appropriate balance of hard evidence and plausible theory that the
behavior of mast cells is integrally related to mural thrombus,
neovascularization, and degeneration of the aortic wall. This study
extends several small animal models that implicate mast cells inaneurysm pathogenesis by demonstrating their presence and be-
havior in human aortic tissue, aneurysmal and normal.
The principle drawback of this study is that it provides only
descriptive or observational results. Furthermore, like all studies
involving human aortic aneurysm tissue, the number of specimens
is relatively small and subject to grading bias. These limitations are
offset by inclusion of normal or control aorta for comparison and
the overall detail of the analysis.
The discussion of the article in particular provides an excellent
review of aneurysm pathogenesis and sets forth a unifying theory on
the relationship of mural thrombus within the aneurysm sac
to inflammatory infiltrates, neovascularization and degeneration
within the aortic wall. The investigators are to be congratulated on
this work and encouraged to continue this line of investigation in
diseased but nonaneurysmal aorta (ie, aortoiliac occlusive disease).
Such investigationmay improve our understandingof the spectrumof
age-related aortic disease and why some aortas are prone to aneurysm
formation while others are prone to occlusive disease only.
